Qube Research & Technologies Ltd
Position in RLMD — Relmada Therapeutics, Inc.
CIK 1729829
LONDON, X0
Position in RLMD
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$4,547,197
+$3,795,992 QoQ
Shares Held
653,333
+320.1% QoQ
Ownership
0.623%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2023
7 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in RLMD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Qube Research & Technologies Ltd holds $2,030,208,323 across 186 Biotechnology names. RLMD ranks #78 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
838,187 | $277,330,932 | |
| 2 | FOLD |
AMICUS THERAPEUTICS, INC.
|
8,809,340 | $127,383,056 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
3,450,904 | $95,590,040 | |
| 4 | RPRX |
Royalty Pharma plc
|
1,524,511 | $73,130,792 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
83,358 | $64,405,725 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
335,334 | $56,678,152 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
553,290 | $53,807,452 | |
| 8 | CYTK |
Cytokinetics Inc
|
779,446 | $51,373,285 |
All Filings in RLMD
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,547,197 | 653,333 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $751,205 | 155,529 | Shares | Sole | 2026-02-17 | |
| 2024-06-30 | $168 | 56 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $339,352 | 72,979 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $20,592 | 4,974 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $11,514 | 3,838 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $112,001 | 45,529 | Shares | Sole | 2023-08-14 | |
| No filing history on record for this holder in this stock. | ||||||